☰

Mark Noble - Publications

Affiliations: 
University of Rochester, Rochester, NY 
Area:
Glial development, multiple sclerosis, brain tumours
Website:
http://www.urmc.rochester.edu/GEBS/faculty/Mark_Noble.htm
Tree Info Grants Similar researchers PubMed Report error

121 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Elfar W, Gurjar AA, Talukder MAH, Noble M, Di Lorenzo C, Elfar J. Erythropoietin promotes functional recovery in a mouse model of postoperative ileus. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. e14049. PMID 33368893 DOI: 10.1111/nmo.14049  0.529
2020 Hsu CG, Talukder MAH, Yue L, Turpin LC, Noble M, Elfar JC. Human equivalent dose of oral 4-aminopyridine differentiates nerve crush injury from transection injury and improves post-injury function in mice. Neural Regeneration Research. 15: 2098-2107. PMID 32394968 DOI: 10.4103/1673-5374.280319  0.591
2020 Clark AR, Hsu CG, Hassan Talukder MA, Noble M, Elfar JC. Transdermal delivery of 4-aminopyridine accelerates motor functional recovery and improves nerve morphology following sciatic nerve crush injury in mice. Neural Regeneration Research. 15: 136-144. PMID 31535662 DOI: 10.4103/1673-5374.264471  0.59
2020 Cortes D, Noble M. Decision letter: Novel C1q receptor-mediated signaling controls neural stem cell behavior and neurorepair Elife. DOI: 10.7554/Elife.55732.Sa1  0.317
2019 Modrak M, Talukder MAH, Gurgenashvili K, Noble M, Elfar JC. Peripheral nerve injury and myelination: Potential therapeutic strategies. Journal of Neuroscience Research. PMID 31608497 DOI: 10.1002/jnr.24538  0.615
2019 Yue L, Talukder MAH, Gurjar A, Lee JI, Noble M, Dirksen R, Chakkalakal J, Elfar JC. 4-Aminopyridine attenuates muscle atrophy after sciatic nerve crush injury in mice. Muscle & Nerve. PMID 31093982 DOI: 10.1002/Mus.26516  0.566
2019 Noble M, Tseng KC, Li H, Elfar JC. 4-Aminopyridine as a Single Agent Diagnostic and Treatment for Severe Nerve Crush Injury. Military Medicine. 184: 379-385. PMID 30901424 DOI: 10.1093/milmed/usy399  0.567
2018 Wang X, Chen H, Stripay J, Noble M. Abstract 1930: Targeting the c-Cbl tumor suppressor protein as a novel therapeutic approach in overcoming acquired tamoxifen resistance in luminal breast cancer Cancer Research. 78: 1930-1930. DOI: 10.1158/1538-7445.Am2018-1930  0.327
2017 Scott-Hewitt NJ, Folts CJ, Hogestyn JM, Piester G, Mayer-Pröschel M, Noble MD. Heterozygote galactocerebrosidase (GALC) mutants have reduced remyelination and impaired myelin debris clearance following demyelinating injury. Human Molecular Genetics. PMID 28575206 DOI: 10.1093/Hmg/Ddx153  0.783
2016 Geary MB, Li H, Zingman A, Ketz J, Zuscik M, De Mesy Bentley KL, Noble M, Elfar JC. Erythropoietin accelerates functional recovery after moderate sciatic nerve crush injury. Muscle & Nerve. PMID 28168703 DOI: 10.1002/Mus.25459  0.569
2016 Folts CJ, Scott-Hewitt N, Pröschel C, Mayer-Pröschel M, Noble M. Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity. Plos Biology. 14: e1002583. PMID 27977664 DOI: 10.1371/Journal.Pbio.1002583  0.78
2016 Tseng KC, Li H, Clark A, Sundem L, Zuscik M, Noble M, Elfar J. 4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury. Embo Molecular Medicine. PMID 27861125 DOI: 10.15252/Emmm.201506035  0.595
2016 Sundem L, Chris Tseng KC, Li H, Ketz J, Noble M, Elfar J. Erythropoietin Enhanced Recovery After Traumatic Nerve Injury: Myelination and Localized Effects. The Journal of Hand Surgery. PMID 27593486 DOI: 10.1016/J.Jhsa.2016.08.002  0.609
2016 Sundem L, Lash E, Noble M, Speach D, Gupta R, Elfar J. Erythropoietin is Neuroprotective During Ongoing Compression and Speeds Recovery Following Surgical Decompression in a Murine Model of Chronic Compression Neuropathy The Journal of Hand Surgery. 41: S48-S49. DOI: 10.1016/J.Jhsa.2016.07.086  0.556
2015 Campbell A, Bushman J, Munger J, Noble M, Pröschel C, Mayer-Pröschel M. Mutation of ataxia-telangiectasia mutated is associated with dysfunctional glutathione homeostasis in cerebellar astroglia. Glia. PMID 26469940 DOI: 10.1002/Glia.22925  0.763
2015 Campbell A, Krupp B, Bushman J, Noble M, Pröschel C, Mayer-Pröschel M. A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden. Human Molecular Genetics. PMID 26310626 DOI: 10.1093/Hmg/Ddv342  0.758
2015 Tanner DC, Campbell A, O'Banion KM, Noble M, Mayer-Pröschel M. cFLIP is critical for oligodendrocyte protection from inflammation. Cell Death and Differentiation. PMID 25633192 DOI: 10.1038/Cdd.2014.237  0.783
2015 Noble M, Mayer-Pröschel M, Li Z, Dong T, Cui W, Pröschel C, Ambeskovic I, Dietrich J, Han R, Yang YM, Folts C, Stripay J, Chen HY, Stevens BM. Redox biology in normal cells and cancer: restoring function of the redox/Fyn/c-Cbl pathway in cancer cells offers new approaches to cancer treatment. Free Radical Biology & Medicine. 79: 300-23. PMID 25481740 DOI: 10.1016/J.Freeradbiomed.2014.10.860  0.745
2015 Elfar JC, Lash E, Menorca RM, Gupta R, Noble M, Speach D. Neuroprotective Potential of Erythropoietin as an Adjuvant to Decompression for Chronic Compression Neuropathy The Journal of Hand Surgery. 40: e36-e37. DOI: 10.1016/J.JHSA.2015.06.064  0.54
2014 Stevens BM, Folts CJ, Cui W, Bardin AL, Walter K, Carson-Walter E, Vescovi A, Noble M. Cool-1-mediated inhibition of c-Cbl modulates multiple critical properties of glioblastomas, including the ability to generate tumors in vivo. Stem Cells (Dayton, Ohio). 32: 1124-35. PMID 24458840 DOI: 10.1002/Stem.1644  0.74
2014 Zingman A, Li H, Tseng K, Noble M, Elfar JC. A Pharmacologic Test to Establish Continuity and Function in the Crush-Injured Nerve The Journal of Hand Surgery. 39: e12. DOI: 10.1016/J.JHSA.2014.06.042  0.566
2013 Wang J, Bushman J, Wang X, Mayer-Proschel M, Johnson M, Noble M. Oligodendrocyte/type-2 astrocyte progenitor cells and glial-restricted precursor cells generate different tumor phenotypes in response to the identical oncogenes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 16805-17. PMID 24133281 DOI: 10.1523/Jneurosci.0546-13.2013  0.804
2013 Chen HY, Yang YM, Han R, Noble M. MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 15069-74. PMID 24048837 DOI: 10.1523/Jneurosci.2729-13.2013  0.629
2013 Noble M, Mayer-Pröschel M, Pröschel C. iOPs: a new tool for studying myelin pathologies? Cell Stem Cell. 12: 503-4. PMID 23642358 DOI: 10.1016/J.Stem.2013.04.021  0.775
2013 Chen HY, Yang YM, Stevens BM, Noble M. Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells. Embo Molecular Medicine. 5: 723-36. PMID 23606532 DOI: 10.1002/Emmm.201202140  0.674
2013 Stevens BM, Folts CJ, Chen W, Bardin AL, Noble M. Abstract 4106: Cool-1-mediated inhibition of c-Cbl as a therapuetic target, which modulates multiple critical properties of glioblastomas. Cancer Research. 73: 4106-4106. DOI: 10.1158/1538-7445.Am2013-4106  0.689
2013 Chen H, Yang Y, Stevens B, Noble M. Abstract 2912: Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumor initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells. Cancer Research. 73: 2912-2912. DOI: 10.1158/1538-7445.Am2013-2912  0.683
2012 Stevens BM, Folts CJ, Bardin AL, Noble M. Abstract 2074: Cool-1-mediated inhibition of c-Cbl modulates multiple critical properties of glioblastomas, including the ability to generate tumorsin vivo Cancer Research. 72: 2074-2074. DOI: 10.1158/1538-7445.Am2012-2074  0.691
2011 Noble M, Mayer-Pröschel M, Davies JE, Davies SJ, Pröschel C. Cell therapies for the central nervous system: how do we identify the best candidates? Current Opinion in Neurology. 24: 570-6. PMID 22027545 DOI: 10.1097/Wco.0B013E32834Cd4C9  0.394
2011 Noble M, Davies JE, Mayer-Pröschel M, Pröschel C, Davies SJ. Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 8: 677-93. PMID 21918888 DOI: 10.1007/S13311-011-0071-Z  0.413
2011 Davies SJ, Shih CH, Noble M, Mayer-Proschel M, Davies JE, Proschel C. Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury. Plos One. 6: e17328. PMID 21407803 DOI: 10.1371/Journal.Pone.0017328  0.807
2011 Noble M, Pröschel C, Mayer-Pröschel M. Oxidative-reductionist approaches to stem and progenitor cell function. Cell Stem Cell. 8: 1-2. PMID 21211773 DOI: 10.1016/J.Stem.2010.12.005  0.803
2011 Chen R, Hyrien O, Noble M, Mayer-Pröschel M. A composite likelihood approach to the analysis of longitudinal clonal data on multitype cellular systems under an age-dependent branching process. Biostatistics (Oxford, England). 12: 173-91. PMID 20732974 DOI: 10.1093/Biostatistics/Kxq050  0.4
2011 Li Z, Proschel C, Noble M. Abstract 282: PAI-2 promotes astrocyte differentiation from glial precursor cells via enhancing STAT3 signaling Cancer Research. 71: 282-282. DOI: 10.1158/1538-7445.Am2011-282  0.456
2011 Stevens BM, Folts CJ, Bardin AL, Noble M. Abstract 1007: The Redox/Fyn/c-Cbl pathway and its interaction with Cool-1: A novel pathway that regulates chemosensitivity in glioblastoma Cancer Research. 71: 1007-1007. DOI: 10.1158/1538-7445.Am2011-1007  0.661
2010 Hyrien O, Dietrich J, Noble M. Mathematical and experimental approaches to identify and predict the effects of chemotherapy on neuroglial precursors. Cancer Research. 70: 10051-9. PMID 21056994 DOI: 10.1158/0008-5472.Can-10-1400  0.486
2010 Hyrien O, Chen R, Mayer-Pröschel M, Noble M. Saddlepoint approximations to the moments of multitype age-dependent branching processes, with applications. Biometrics. 66: 567-77. PMID 19508238 DOI: 10.1111/J.1541-0420.2009.01281.X  0.357
2010 Ana NT, Han R, Sprentall K, Santoni O, Noble M. Abstract 2611: Cisplatin negatively affects CNS progenitor cells and behavior in the adult mouse Cancer Research. 70: 2611-2611. DOI: 10.1158/1538-7445.Am10-2611  0.411
2009 Stevens B, Folts C, Cui W, Noble M. Abstract A159: The Redox/ Fyn/c‐Cbl pathway and its interaction with Cool‐1: A novel pathway that regulates chemosensitivity in glioblastoma Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A159  0.68
2008 Davies JE, Pröschel C, Zhang N, Noble M, Mayer-Pröschel M, Davies SJ. Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. Journal of Biology. 7: 24. PMID 18803859 DOI: 10.1186/Jbiol85  0.547
2008 Han R, Yang YM, Dietrich J, Luebke A, Mayer-Pröschel M, Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. Journal of Biology. 7: 12. PMID 18430259 DOI: 10.1186/Jbiol69  0.781
2007 Li Z, Dong T, Pröschel C, Noble M. Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function. Plos Biology. 5: e35. PMID 17298174 DOI: 10.1371/journal.pbio.0050035  0.364
2007 Noble M. Redox regulation of progenitor cell function in development and pathology The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A36-B  0.411
2006 Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. Journal of Biology. 5: 22. PMID 17125495 DOI: 10.1186/Jbiol50  0.632
2006 Jordan CT, Guzman ML, Noble M. Cancer stem cells. The New England Journal of Medicine. 355: 1253-61. PMID 16990388 DOI: 10.1056/Nejmra061808  0.352
2006 Hyrien O, Ambeskovic I, Mayer-Proschel M, Noble M, Yakovlev A. Stochastic modeling of oligodendrocyte generation in cell culture: model validation with time-lapse data. Theoretical Biology & Medical Modelling. 3: 21. PMID 16707014 DOI: 10.1186/1742-4682-3-21  0.774
2006 Davies JE, Huang C, Proschel C, Noble M, Mayer-Proschel M, Davies SJ. Astrocytes derived from glial-restricted precursors promote spinal cord repair. Journal of Biology. 5: 7. PMID 16643674 DOI: 10.1186/Jbiol35  0.792
2006 Noble M. Implications for CNS repair of redox modulation of cell survival, division and differentiation. Current Alzheimer Research. 3: 37-47. PMID 16472202 DOI: 10.2174/156720506775697188  0.451
2005 Noble M. Ethics in the trenches: a multifaceted analysis of the stem cell debate. Stem Cell Reviews. 1: 345-76. PMID 17142878 DOI: 10.1385/SCR:1:4:345  0.375
2005 Noble M, Mayer-Pröschel M, Pröschel C. Redox regulation of precursor cell function: insights and paradoxes. Antioxidants & Redox Signaling. 7: 1456-67. PMID 16356108 DOI: 10.1089/Ars.2005.7.1456  0.455
2005 Hyrien O, Mayer-Pröschel M, Noble M, Yakovlev A. Estimating the life-span of oligodendrocytes from clonal data on their development in cell culture. Mathematical Biosciences. 193: 255-74. PMID 15748733 DOI: 10.1016/J.Mbs.2004.07.003  0.444
2005 Hyrien O, Mayer-Pröschel M, Noble M, Yakovlev A. A stochastic model to analyze clonal data on multi-type cell populations. Biometrics. 61: 199-207. PMID 15737094 DOI: 10.1111/J.0006-341X.2005.031210.X  0.429
2005 Dietrich J, Lacagnina M, Gass D, Richfield E, Mayer-Pröschel M, Noble M, Torres C, Pröschel C. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nature Medicine. 11: 277-83. PMID 15723074 DOI: 10.1038/Nm1195  0.395
2004 Hill CE, Proschel C, Noble M, Mayer-Proschel M, Gensel JC, Beattie MS, Bresnahan JC. Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration. Experimental Neurology. 190: 289-310. PMID 15530870 DOI: 10.1016/J.Expneurol.2004.05.043  0.809
2004 Noble M, Pröschel C, Mayer-Pröschel M. Getting a GR(i)P on oligodendrocyte development. Developmental Biology. 265: 33-52. PMID 14697351 DOI: 10.1016/J.Ydbio.2003.06.002  0.467
2004 Noble M. The possible role of myelin destruction as a precipitating event in Alzheimer's disease. Neurobiology of Aging. 25: 25-31. PMID 14675726 DOI: 10.1016/j.neurobiolaging.2003.07.001  0.341
2003 Noble M, Arhin A, Gass D, Mayer-Pröschel M. The cortical ancestry of oligodendrocytes: common principles and novel features. Developmental Neuroscience. 25: 217-33. PMID 12966219 DOI: 10.1159/000072270  0.43
2003 Noble M, Smith J, Power J, Mayer-Pröschel M. Redox state as a central modulator of precursor cell function. Annals of the New York Academy of Sciences. 991: 251-71. PMID 12846992 DOI: 10.1111/J.1749-6632.2003.Tb07481.X  0.416
2002 Dietrich J, Noble M, Mayer-Proschel M. Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia. 40: 65-77. PMID 12237844 DOI: 10.1002/Glia.10116  0.811
2002 Power J, Mayer-Pröschel M, Smith J, Noble M. Oligodendrocyte precursor cells from different brain regions express divergent properties consistent with the differing time courses of myelination in these regions. Developmental Biology. 245: 362-75. PMID 11977987 DOI: 10.1006/Dbio.2002.0610  0.388
2002 Noble M, Dietrich J. Intersections between neurobiology and oncology: tumor origin, treatment and repair of treatment-associated damage. Trends in Neurosciences. 25: 103-7. PMID 11814563 DOI: 10.1016/S0166-2236(02)02060-X  0.373
2002 Gregori N, Pröschel C, Noble M, Mayer-Pröschel M. The tripotential glial-restricted precursor (GRP) cell and glial development in the spinal cord: generation of bipotential oligodendrocyte-type-2 astrocyte progenitor cells and dorsal-ventral differences in GRP cell function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 248-56. PMID 11756508 DOI: 10.1523/Jneurosci.22-01-00248.2002  0.456
2001 Boucher K, Zorin A, Yakovlev AY, Mayer-Proschel M, Noble M. An alternative stochastic model of generation of oligodendrocytes in cell culture. Journal of Mathematical Biology. 43: 22-36. PMID 12120865 DOI: 10.1007/S002850100085  0.816
2001 Mayer-Pröschel M, Morath D, Noble M. Are hypothyroidism and iron deficiency precursor cell diseases? Developmental Neuroscience. 23: 277-86. PMID 11756743 DOI: 10.1159/000048711  0.411
2000 Noble M. Can neural stem cells be used to track down and destroy migratory brain tumor cells while also providing a means of repairing tumor-associated damage? Proceedings of the National Academy of Sciences of the United States of America. 97: 12393-5. PMID 11070073 DOI: 10.1073/pnas.97.23.12393  0.372
2000 Zorin A, Mayer-Proschel M, Noble M, Yakovlev AY. Estimation problems associated with stochastic modeling of proliferation and differentiation of O-2A progenitor cells in vitro. Mathematical Biosciences. 167: 109-21. PMID 10998484 DOI: 10.1016/S0025-5564(00)00040-7  0.804
2000 Smith J, Ladi E, Mayer-Proschel M, Noble M. Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proceedings of the National Academy of Sciences of the United States of America. 97: 10032-7. PMID 10944195 DOI: 10.1073/Pnas.170209797  0.791
2000 Noble M. Can neural stem cells be used as therapeutic vehicles in the treatment of brain tumors? Nature Medicine. 6: 369-70. PMID 10742131 DOI: 10.1038/74610  0.351
2000 Noble M. Precursor cell transitions in oligodendrocyte development. The Journal of Cell Biology. 148: 839-42. PMID 10704434 DOI: 10.1083/jcb.148.5.839  0.376
2000 Yakovlev AY, Von Collani E, Mayer-Proschel M, Noble M. Stochastic formulations of a clock model for temporally regulated generation of oligodendrocytes in vitro Mathematical and Computer Modelling. 32: 125-137. DOI: 10.1016/S0895-7177(00)00124-2  0.815
1999 von Collani E, Tsodikov A, Yakovlev A, Mayer-Proschel M, Noble M. A random walk model of oligodendrocyte generation in vitro and associated estimation problems. Mathematical Biosciences. 159: 189-204. PMID 10414033 DOI: 10.1016/S0025-5564(99)00017-6  0.795
1999 Boucher K, Yakovlev AY, Mayer-Proschel M, Noble M. A stochastic model of temporally regulated generation of oligodendrocytes in cell culture. Mathematical Biosciences. 159: 47-78. PMID 10361805 DOI: 10.1016/S0025-5564(99)00010-3  0.81
1998 Mao X, Barfoot R, Hamoudi RA, Noble M. Alleletyping of an oligodendrocyte-type-2 astrocyte lineage derive from a human glioblastoma multiforme Journal of Neuro-Oncology. 40: 243-250. PMID 10066097 DOI: 10.1023/A:1006158010388  0.419
1998 Yakovlev AY, Boucher K, Mayer-Proschel M, Noble M. Quantitative insight into proliferation and differentiation of oligodendrocyte type 2 astrocyte progenitor cells in vitro. Proceedings of the National Academy of Sciences of the United States of America. 95: 14164-7. PMID 9826671 DOI: 10.1073/Pnas.95.24.14164  0.816
1998 Yakovlev AY, Mayer-Proschel M, Noble M. A stochastic model of brain cell differentiation in tissue culture. Journal of Mathematical Biology. 37: 49-60. PMID 9710974 DOI: 10.1007/S002850050119  0.835
1998 Rao MS, Noble M, Mayer-Pröschel M. A tripotential glial precursor cell is present in the developing spinal cord. Proceedings of the National Academy of Sciences of the United States of America. 95: 3996-4001. PMID 9520481 DOI: 10.1073/Pnas.95.7.3996  0.444
1997 Noble M, Mayer-Pröschel M. Growth factors, glia and gliomas. Journal of Neuro-Oncology. 35: 193-209. PMID 9440020 DOI: 10.1023/A:1005898228116  0.436
1997 Florian CL, Pietsch T, Noble M, Williams SR. Metabolic studies of human primitive neuroectodermal tumour cells by proton nuclear magnetic resonance spectroscopy. British Journal of Cancer. 75: 1007-13. PMID 9083336 DOI: 10.1038/Bjc.1997.173  0.397
1997 Yakolev AY, Mayer-Proschel M, Noble M. A stochastic model of oligodendrocyte generation in culture Cell Proliferation. 30: 244.  0.779
1996 Ibarrola N, Mayer-Pröschel M, Rodriguez-Peña A, Noble M. Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. Developmental Biology. 180: 1-21. PMID 8948570 DOI: 10.1006/Dbio.1996.0280  0.467
1996 Bhakoo KK, Williams IT, Williams SR, Gadian DG, Noble MD. Proton nuclear magnetic resonance spectroscopy of primary cells derived from nervous tissue. Journal of Neurochemistry. 66: 1254-63. PMID 8769892  0.309
1995 Noble M, Gutowski N, Bevan K, Engel U, Linskey M, Urenjak J, Bhakoo K, Williams S. From rodent glial precursor cell to human glial neoplasia in the oligodendrocyte-type-2 astrocyte lineage Glia. 15: 222-230. PMID 8586459 DOI: 10.1002/Glia.440150304  0.423
1995 Noble M, Groves AK, Ataliotis P, Ikram Z, Jat PS. The H-2KbtsA58 transgenic mouse: a new tool for the rapid generation of novel cell lines. Transgenic Research. 4: 215-25. PMID 7655511 DOI: 10.1007/Bf01969114  0.588
1994 Bögler O, Noble M. Measurement of time in oligodendrocyte-type-2 astrocyte (O-2A) progenitors is a cellular process distinct from differentiation or division Developmental Biology. 162: 525-538. PMID 8150211 DOI: 10.1006/Dbio.1994.1106  0.399
1994 Mayer M, Noble M. N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro Proceedings of the National Academy of Sciences of the United States of America. 91: 7496-7500. PMID 7914368 DOI: 10.1073/pnas.91.16.7496  0.33
1993 Mayer M, Bögler O, Noble M. The inhibition of oligodendrocytic differentiation of O-2A progenitors caused by basic fibroblast growth factor is overridden by astrocytes Glia. 8: 12-19. PMID 8509161 DOI: 10.1002/Glia.440080103  0.35
1993 Groves AK, Barnett SC, Franklin RJ, Crang AJ, Mayer M, Blakemore WF, Noble M. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature. 362: 453-5. PMID 8464477 DOI: 10.1038/362453A0  0.595
1993 Groves AK, Entwistle A, Jat PS, Noble M. The characterization of astrocyte cell lines that display properties of glial scar tissue. Developmental Biology. 159: 87-104. PMID 8365576 DOI: 10.1006/dbio.1993.1223  0.585
1993 Barnett SC, Hutchins AM, Noble M. Purification of olfactory nerve ensheathing cells from the olfactory bulb Developmental Biology. 155: 337-350. PMID 7679359 DOI: 10.1006/Dbio.1993.1033  0.384
1993 Bögler O, Entwistle A, Kuhn R, Monuki E, Lemke G, Noble M. Single cell analysis of the expression of a nuclear protein, SCIP, by fluorescent immunohistochemistry visualized with confocal microscopy The Histochemical Journal. 25: 746-761. PMID 7506703 DOI: 10.1007/Bf00211770  0.343
1993 Noble M, Groves AK, Ataliotis P, Morgan J, Peckham M, Partridge T, Jat PS. Biological and Molecular Approaches to the Generation of Conditionally Immortal Neural Cells Neuroprotocols. 3: 189-199. DOI: 10.1006/Ncmn.1993.1054  0.625
1992 Wren D, Wolswijk G, Noble M. In vitro analysis of the origin and maintenance of O-2Aadult progenitor cells. Journal of Cell Biology. 116: 167-176. PMID 1730741 DOI: 10.1083/Jcb.116.1.167  0.352
1992 Urenjak J, Williams SR, Gadian DG, Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. Journal of Neurochemistry. 59: 55-61. PMID 1613513 DOI: 10.1111/J.1471-4159.1992.Tb08875.X  0.387
1992 Noble M, Wren D, Wolswijk G. The O-2Aadult progenitor cell: a glial stem cell of the adult central nervous system Seminars in Cell Biology. 3: 413-422. PMID 1489973 DOI: 10.1016/1043-4682(92)90012-K  0.439
1992 Noble M, Wolswijk G. Development of regeneration in the O-2A lineage: studies in vitro and in vivo Journal of Neuroimmunology. 40: 287-293. PMID 1430159 DOI: 10.1016/0165-5728(92)90145-B  0.314
1992 Crang AJ, Franklin RJ, Blakemore WF, Noble M, Barnett SC, Groves A, Trotter J, Schachner M. The differentiation of glial cell progenitor populations following transplantation into non-repairing central nervous system glial lesions in adult animals. Journal of Neuroimmunology. 40: 243-53. PMID 1430154 DOI: 10.1016/0165-5728(92)90140-G  0.57
1992 Noble M, Groves AK, Ataliotis P, Jat PS. From chance to choice in the generation of neural cell lines. Brain Pathology (Zurich, Switzerland). 2: 39-46. PMID 1341946  0.528
1992 Wolswijk G, Noble M. Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells. Journal of Cell Biology. 118: 889-900. PMID 1323567 DOI: 10.1083/Jcb.118.4.889  0.45
1991 Wolswijk G, Riddle PN, Noble M. Platelet-derived growth factor is mitogenic for O-2Aadult progenitor cells. Glia. 4: 495-503. PMID 1834566 DOI: 10.1002/Glia.440040509  0.355
1991 Noble M. Points of controversy in the O-2A lineage: clocks and type-2 astrocytes. Glia. 4: 157-164. PMID 1827775 DOI: 10.1002/Glia.440040207  0.349
1991 Bögler O, Noble M. Studies relating differentiation to a mechanism that measures time in O-2A progenitor cells. Annals of the New York Academy of Sciences. 633: 505-507. PMID 1789568 DOI: 10.1111/J.1749-6632.1991.Tb15641.X  0.351
1991 Wolswijk G, Munro PM, Riddle PN, Noble M. Origin, growth factor responses, and ultrastructural characteristics of an adult-specific glial progenitor cell. Annals of the New York Academy of Sciences. 633: 502-4. PMID 1789567 DOI: 10.1111/J.1749-6632.1991.Tb15640.X  0.338
1991 Noble M, Ataliotis P, Barnett SC, Bevan K, Bögler O, Groves A, Jat P, Wolswijk G, Wren D. Development, regeneration, and neoplasia of glial cells in the central nervous system. Annals of the New York Academy of Sciences. 633: 35-47. PMID 1789559 DOI: 10.1111/J.1749-6632.1991.Tb15593.X  0.607
1991 Groves AK, Bögler O, Jat PS, Noble M. The cellular measurement of time. Current Opinion in Cell Biology. 3: 224-9. PMID 1715728 DOI: 10.1016/0955-0674(91)90143-M  0.49
1990 Bögler O, Wren D, Barnett SC, Land H, Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells Proceedings of the National Academy of Sciences of the United States of America. 87: 6368-6372. PMID 2201028 DOI: 10.1073/Pnas.87.16.6368  0.416
1990 Noble M, Fok-Seang J, Wolswijk G, Wren D. Development and regeneration in the central nervous system. Philosophical Transactions of the Royal Society B. 327: 127-143. PMID 1969654 DOI: 10.1098/Rstb.1990.0049  0.445
1989 Noble M, Wolswijk G, Wren D. The complex relationship between cell division and the control of differentiation in oligodendrocyte-type-2 astrocyte progenitor cells isolated from perinatal and adult rat optic nerves. Progress in Growth Factor Research. 1: 179-194. PMID 2491261 DOI: 10.1016/0955-2235(89)90010-0  0.454
1989 Wolswijk G, Wren D, Munro P, Noble M. Identification of an adult-specific glial progenitor cell Mechanisms of Development. 27: 203. DOI: 10.1016/0922-3371(89)90618-7  0.368
1988 Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature. 333: 562-5. PMID 3287177 DOI: 10.1038/333562a0  0.595
1988 Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature. 333: 560-562. PMID 3287176 DOI: 10.1038/333560A0  0.425
1988 Calder VL, Wolswijk G, Noble M. The differentiation of O-2A progenitor cells into oligodendrocytes is associated with a loss of inducibility of Ia antigens. European Journal of Immunology. 18: 1195-1201. PMID 3138136 DOI: 10.1002/Eji.1830180808  0.399
1988 Ridley AJ, Paterson HF, Noble M, Land H. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. The Embo Journal. 7: 1635-1645. DOI: 10.1002/J.1460-2075.1988.Tb02990.X  0.346
1987 Small RK, Riddle P, Noble M. Evidence for migration of oligodendrocyte--type-2 astrocyte progenitor cells into the developing rat optic nerve. Nature. 328: 155-157. PMID 3600791 DOI: 10.1038/328155A0  0.432
1985 Murray K, Noble M. In vitro studies on the comparative sensitivities of cells of the central nervous system to diphtheria toxin Journal of the Neurological Sciences. 70: 283-293. PMID 4056824 DOI: 10.1016/0022-510X(85)90170-4  0.42
1984 Noble M, Fok-Seang J, Cohen J. Glia are a unique substrate for the in vitro growth of central nervous system neurons The Journal of Neuroscience. 4: 1892-1903. DOI: 10.1523/Jneurosci.04-07-01892.1984  0.32
1984 Noble M, Murray K. Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. The Embo Journal. 3: 2243-2247. DOI: 10.1002/J.1460-2075.1984.Tb02122.X  0.472
1983 Raff MC, Miller RH, Noble M. Glial cell lineages in the rat optic nerve. Cold Spring Harbor Symposia On Quantitative Biology. 48: 569-72. PMID 6586375 DOI: 10.1101/Sqb.1983.048.01.061  0.589
1983 Raff MC, Abney ER, Cohen J, Lindsay R, Noble M. Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 3: 1289-1300. PMID 6343560 DOI: 10.1523/Jneurosci.03-06-01289.1983  0.563
1983 Raff MC, Miller RH, Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature. 303: 390-6. PMID 6304520 DOI: 10.1038/303390a0  0.692
1983 Rougon G, Noble M, Mudge AW. Neuropeptides modulate the β-adrenergic response of purified astrocytes in vitro Nature. 305: 715-717. PMID 6195528 DOI: 10.1038/305715A0  0.331
1981 Bartlett PF, Noble MD, Pruss RM, Raff MC, Rattray S, Williams CA. Rat neural antigen-2 (RAN-2): a cell surface antigen on astrocytes, ependymal cells, Müller cells and lepto-meninges defined by a monoclonal antibody. Brain Research. 204: 339-51. PMID 7006734 DOI: 10.1016/0006-8993(81)90593-X  0.539
Show low-probability matches.